GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,355,000 | +3.1% | 31,122 | +3.2% | 0.01% | +18.2% |
| Q1 2022 | $1,314,000 | +2.6% | 30,154 | +3.7% | 0.01% | +10.0% |
| Q4 2021 | $1,281,000 | +14.8% | 29,065 | -0.6% | 0.01% | 0.0% |
| Q3 2021 | $1,116,000 | -8.1% | 29,232 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $1,214,000 | +22.1% | 30,475 | +9.4% | 0.01% | +11.1% |
| Q1 2021 | $994,000 | +1.6% | 27,858 | +4.8% | 0.01% | 0.0% |
| Q4 2020 | $978,000 | -10.5% | 26,575 | -8.5% | 0.01% | -25.0% |
| Q3 2020 | $1,093,000 | -9.3% | 29,038 | -1.7% | 0.01% | -14.3% |
| Q2 2020 | $1,205,000 | +7.9% | 29,540 | +0.2% | 0.01% | -6.7% |
| Q1 2020 | $1,117,000 | -29.2% | 29,478 | -12.1% | 0.02% | -11.8% |
| Q4 2019 | $1,577,000 | +10.7% | 33,549 | +0.6% | 0.02% | +6.2% |
| Q3 2019 | $1,424,000 | +17.3% | 33,362 | +9.9% | 0.02% | +14.3% |
| Q2 2019 | $1,214,000 | -7.5% | 30,353 | -3.3% | 0.01% | -6.7% |
| Q1 2019 | $1,312,000 | +7.0% | 31,397 | -2.2% | 0.02% | 0.0% |
| Q4 2018 | $1,226,000 | -7.3% | 32,088 | -2.5% | 0.02% | +7.1% |
| Q3 2018 | $1,322,000 | -7.4% | 32,917 | -7.0% | 0.01% | -12.5% |
| Q2 2018 | $1,427,000 | -0.3% | 35,400 | -3.5% | 0.02% | 0.0% |
| Q1 2018 | $1,432,000 | +7.6% | 36,665 | -2.3% | 0.02% | +14.3% |
| Q4 2017 | $1,331,000 | -11.4% | 37,531 | +1.5% | 0.01% | -17.6% |
| Q3 2017 | $1,502,000 | -12.1% | 36,993 | -6.7% | 0.02% | -15.0% |
| Q2 2017 | $1,709,000 | -0.1% | 39,646 | -2.3% | 0.02% | 0.0% |
| Q1 2017 | $1,710,000 | +17.0% | 40,559 | +6.9% | 0.02% | +11.1% |
| Q4 2016 | $1,461,000 | -11.3% | 37,951 | -0.6% | 0.02% | -14.3% |
| Q3 2016 | $1,647,000 | -7.3% | 38,188 | -6.9% | 0.02% | -8.7% |
| Q2 2016 | $1,777,000 | +7.8% | 41,011 | +0.9% | 0.02% | +4.5% |
| Q1 2016 | $1,648,000 | +5.8% | 40,638 | +5.3% | 0.02% | +4.8% |
| Q4 2015 | $1,558,000 | +6.1% | 38,604 | +1.1% | 0.02% | 0.0% |
| Q3 2015 | $1,468,000 | -9.4% | 38,168 | -2.0% | 0.02% | -4.5% |
| Q2 2015 | $1,621,000 | -8.8% | 38,935 | +1.1% | 0.02% | -4.3% |
| Q1 2015 | $1,778,000 | -5.0% | 38,521 | -12.0% | 0.02% | -4.2% |
| Q4 2014 | $1,872,000 | +14.5% | 43,790 | +23.1% | 0.02% | +20.0% |
| Q3 2014 | $1,635,000 | -54.7% | 35,583 | -47.3% | 0.02% | -54.5% |
| Q2 2014 | $3,611,000 | -1.0% | 67,520 | -1.0% | 0.04% | -4.3% |
| Q1 2014 | $3,646,000 | +0.4% | 68,231 | +0.3% | 0.05% | +2.2% |
| Q4 2013 | $3,631,000 | +71.6% | 68,013 | +61.3% | 0.04% | +60.7% |
| Q3 2013 | $2,116,000 | -2.3% | 42,177 | -2.6% | 0.03% | -6.7% |
| Q2 2013 | $2,165,000 | – | 43,311 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |